Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma-Reference-Cited by-同舟云学术

Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma

Published:2020-06-27 Issue:8 Volume:24 Page:777-792
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Gauvreau Gail M.¹^ORCID,Sehmi Roma¹^ORCID,Ambrose Christopher S.²^ORCID,Griffiths Janet M.³^ORCID

Affiliation:

1. Department of Medicine, McMaster University, Hamilton, Ontario, Canada

2. Respiratory & Immunology, BioPharmaceuticals Medical, Gaithersburg, MD, USA

3. Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, Gaithersburg, MD, USA

Funder

manuscript was funded by funded by AstraZeneca and Amgen

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1783242

Reference151 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2019. [cited 2020 Jan 27]. Available from: http://ginasthma.org/gina-reports/

3. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment

4. T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

5. Different endotypes and phenotypes drive the heterogeneity in severe asthma

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on potential therapeutic targets for the treatment of leishmaniasis;Parasitology International;2024-06

2. テゼペルマブ（テゼスパイア<sup>®</sup>皮下注210 ‍mgシリンジ・ペン）の薬理学的特徴及び気管支喘息に対する臨床試験成績;Folia Pharmacologica Japonica;2024-01-01

3. Tezepelumab in patients with allergic and eosinophilic asthma;Allergy;2023-12-26

4. JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma;Science Advances;2023-12-22

5. Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study;Pulmonary Therapy;2023-12-08